Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brent Saunders
Pharma
After M&A rumors, Bausch + Lomb confirms it's exploring a sale
Bausch + Lomb said that its board has authorized management to pursue its sale. The statement came in response to inquiries about its volatile stock.
Kevin Dunleavy
Dec 12, 2024 11:26am
Veteran Big Pharma chief slams Carlson, Musk’s drug ad criticism
Dec 4, 2023 4:08am
J&J unloads eye drops line to acquisitive Bausch + Lomb
Jul 6, 2023 10:29am
Bausch + Lomb runs it back with dealmaker Brent Saunders as CEO
Feb 15, 2023 11:33am
Ex-Allergan chief Saunders returns to beauty with $1.1B buyout
Dec 9, 2020 11:37am
Ex-Allergan CEO jumps to biotech with board seat at BridgeBio
Jun 24, 2020 12:15pm
